The regenerative medicine industry is expanding at an undeniably rapid clip. Advances in cell and gene technologies, tis...
British pharmaceutical firm AstraZeneca has entered into a definitive agreement to acquire Belgium-based biotech startup...
The L V Prasad Eye Institute (LVPEI), Hyderabad, India has been granted an Australian patent for a novel cell therapy th...
ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...
Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...
Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...
Japan's Sumitomo Chemical Co. and Sumitomo Pharma have studied restructuring measures to accelerate the development of r...
Japan-based GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell th...
South Korea-based GC Cell, a leading innovator in cell therapy, has announced the execution of a landmark 'Technology Tr...
STEMCELL Technologies has launched the CellPore™ Transfection System, a new technology with the potential to...
Japan-headquartered Astellas Pharma Inc. and Graduate School of Medicine / Faculty of Medicine, Osaka University ha...
Japan-based Healios K.K. has entered into a license agreement with Astellas Institute for Regenerative Medicine (A...
US-based Charles River Laboratories International, Inc. and National University of Singapore’s (NUS) Yon...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing...
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...
I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies based in Palo Alto...
The Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) launched a new 2,000 sqm cell therapy facility...
